LEADER 04147nam  2200733 a 450 
001 9910806162503321
005 20240516065051.0
010   $a9786613694461
010   $a9781280784071
010   $a1280784075
010   $a9780470720738
010   $a0470720735
010   $a9780470718421
010   $a0470718420
035   $a(CKB)1000000000688145
035   $a(EBL)703912
035   $a(OCoLC)797918492
035   $a(SSID)ssj0000715489
035   $a(PQKBManifestationID)11435131
035   $a(PQKBTitleCode)TC0000715489
035   $a(PQKBWorkID)10701713
035   $a(PQKB)11341815
035   $a(MiAaPQ)EBC703912
035   $a(Au-PeEL)EBL703912
035   $a(CaPaEBR)ebr10575664
035   $a(CaONFJC)MIL369446
035   $a(Perlego)2776629
035   $a(EXLCZ)991000000000688145
100   $a19831122d1982      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aSubstance P in the nervous system
205   $a1st ed.
210   $aLondon $cPitman ;$aSummit, N.J., USA $cDistributed in North America by Ciba Pharmaceutical Co., Medical Education Administration$d1982
215   $a1 online resource (362 p.)
225 1 $aCiba Foundation symposium ;$v91
300   $a"Editors: Ruth Porter (organizer) and Maeve O'Connor"--P. v.
311 08$a9780470664087 
311 08$a0470664088 
311 08$a9780272796559 
311 08$a0272796557 
320   $aIncludes bibliographical references and indexes.
327   $aSubstance P in the nervous system; Contents; Introduction; Chemical neurotransmission-yesterday and today; Role of substance P as a sensory transmitter in spinal cord and sympathetic ganglia; Discussion; Substance P in peripheral sensory processes; Discussion; Localization of substance P in neuronal pathways; Discussion; Distribution of substance P in brain and periphery and its possible role as a co-transmitter; Discussion; Regulation of substance P expression and metabolism in vivo and in vitro; Discussion; GENERAL DISCUSSION; Coexistence of transmitters
327   $aSubstance P in nerve tissue in the gut Discussion; Biosynthesis, axonal transport and turnover of neuronal substance P; Discussion; Enzymic inactivation of substance P in the central nervous system; Discussion; Substance P receptors in the nervous system and possible receptor subtypes; Discussion; Relation of substance P to pain transmission: neurophysiological evidence; Discussion; Substance P in nociceptive sensory neurons; Discussion; If substance P fails to fulfil the criteria as a neurotransmitter in somatosensory afferents, what might be its function?; Discussion
327   $aModulation of cholinergic transmission by substance PDiscussion; The striatonigral substance P pathway and dopaminergic mechanisms; Discussion; Relation of substance P to stress and catecholamine metabolism; Discussion; Behavioural effects of substance P through dopaminergic pathways in the brain; Discussion; FINAL GENERAL DISCUSSION; Substance P antagonists; tumour cell lines and substance P; substance P and other tachykinins; substance P and clinical pain syndromes; substance P and neuronal systems; Index of contributors; Subject index
330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 
410  0$aCiba Foundation symposium ;$v91.
606   $aSubstance P$vCongresses
606   $aNeurology$vCongresses
615  0$aSubstance P
615  0$aNeurology
676   $a599/.0188
701   $aPorter$b Ruth$064811
701   $aO'Connor$b Maeve$0284912
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910806162503321
996   $aSubstance P in the nervous system$91963079
997   $aUNINA